T
Thomas Dailey
Researcher at Amicus Therapeutics
Publications - 1
Citations - 53
Thomas Dailey is an academic researcher from Amicus Therapeutics. The author has contributed to research in topics: Induced pluripotent stem cell & CD38. The author has an hindex of 1, co-authored 1 publications receiving 1 citations.
Papers
More filters
Journal ArticleDOI
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy
Karrune Woan,Hansol Kim,Ryan Bjordahl,Zachary Davis,Svetlana Gaidarova,John Goulding,Brian Hancock,Sajid Mahmood,Ramzey Abujarour,Hongbo Wang,Katie Tuininga,Bin Zhang,Cheng-Ying Wu,Behiye Kodal,Melissa Khaw,Laura Bendzick,Paul Rogers,Moyar Q. Ge,Greg Bonello,Miguel Meza,Martin Felices,Janel Huffman,Thomas Dailey,Tom Tong Lee,Bruce Walcheck,Karl J. Malmberg,Bruce R. Blazar,Yenan T. Bryceson,Bahram Valamehr,Jeffrey S. Miller,Frank Cichocki +30 more
TL;DR: In this article, a triple-gene-edited induced pluripotent stem cell (iPSC) line was generated to express a high affinity, non-cleavable version of the Fc receptor CD16a and a membrane bound interleukin (IL)-15/IL-15R fusion protein.